Hyam I. Levitsky M.D. — Chief Scientific Officer and Executive Vice President of Research at Juno Therapeutics

Dr. Hyam I. Levitsky, also known as Hy, M.D has been the Chief Scientific Officer and Executive Vice President of Research at Juno Therapeutics Inc. since May 28, 2015. Prior to joining Juno, Dr. Levitsky served as the Head of Cancer Immunology Experimental Medicine of Roche Holding AG since September 1, 2011. Dr. Levitsky's laboratory research involves basic studies of antigen processing and presentation, T-cell co-stimulation, T-cell priming versus tolerance and the evolution of tumor-specific immunity during immune reconstitution. His work has been translated into the creation of novel therapeutic agents that are being tested in patients with multiple Myeloma, acute and chronic myelogenous leukemia, B cell lymphomas, prostate cancer and lung cancer. His work on manipulating immune reconstitution has led to pivotal trials of tumor vaccines in the context of autologous stem cell transplantation and he served as Scientific Director of the George Santos Bone Marrow Transplant Program at Johns Hopkins. Dr. Levitsky serves as a Professor of Oncology, Medicine and Urology at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Dr. Levitsky served as a Director of Agenus Inc. from September 13, 2006 to August 2011. Dr. Levitsky served as a Member of the Scientific Advisory Board of Celldex Therapeutics Inc. Dr. Levitsky served as a Member of the Scientific Advisory Board of Xcyte Therapies Inc. He has received numerous awards for his research, including the Stohlman Scholars Award from the Leukemia and Lymphoma Foundation of America, The Senior Research Award from the Multiple Myeloma Research Foundation, Research Awards from the CapCURE foundation, The American Cancer Society and the National Institutes of Health. In 2001, he was elected to the American Society for Clinical Investigation. Dr. Levitsky received his BS in Engineering from the University of Pennsylvania School of Engineering and Applied Science in 1980 and his Medical Degree from the Johns Hopkins University School of Medicine in 1984. He did his Internship and Residency in Internal Medicine at Johns Hopkins Hospital and his Fellowship at the Johns Hopkins Oncology Center.